Long-term follow-up of patients with hypoparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 12, 2012, Pages 4507-4514

  Mitchell, Deborah M ^a   Regan, Susan ^a   Cooley, Michael R ^a   Lauter, Kelly B ^a   Vrla, Michael C ^a   Becker, Carolyn B ^b   Burnett Bowie, Sherri Ann M ^a   Mannstadt, Michael ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; CHLORTALIDONE; COLECALCIFEROL; ERGOCALCIFEROL; HYDROCHLOROTHIAZIDE; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; THIAZIDE DIURETIC AGENT; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL GANGLION; BONE DENSITY; BRAIN CALCIFICATION; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM URINE LEVEL; CHILD; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DISEASE COURSE; DRUG MEGADOSE; ECHOGRAPHY; FEMALE; FOLLOW UP; FRACTURE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCALCIURIA; HYPERTENSION; HYPOCALCEMIA; HYPOPARATHYROIDISM; KIDNEY CALCIFICATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TERTIARY HEALTH CARE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOPARATHYROIDISM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84870740912     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1808     Document Type: Article

References (32)

1. Shoback D 2008 Clinical practice. Hypoparathyroidism. N Engl J Med 359:391-403
2. Bilezikian JP, Khan A, Potts Jr JT, Brandi ML, Clarke BL, Shoback D, Jüppner H, D'Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J 2011 Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26:2317-2337
3. Marx SJ 2000 Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 343:1863-1875 (Pubitemid 32104134)
4. Parkinson DB, Thakker RV 1992 A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism. Nat Genet 1:149-152
5. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115-1122 (Pubitemid 26330965)
6. Thakker RV 2001 Genetic developments in hypoparathyroidism. Lancet 357:974-976 (Pubitemid 32285386)
7. Ding C, Buckingham B, Levine MA 2001 Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 108:1215-1220 (Pubitemid 32995380)
8. Santos F, Chan JC 1986 Idiopathic hypoparathyroidism: a case study on the interactions between exogenous parathyroid hormone infusion and 1,25-dihydroxyvitamin D. Pediatrics 78:1139-1141 (Pubitemid 17190259)
9. Weber G, Cazzuffi MA, Frisone F, de Angelis M, Pasolini D, Tomaselli V, Chiumello G 1988 Nephrocalcinosis in children and adolescents: sonographic evaluation during long-term treatment with 1,25-dihydroxycholecalciferol. Child Nephrol Urol 9:273-276 (Pubitemid 20071422)
10. Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B 2002 Well-being,moodand calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215-222 (Pubitemid 34162914)
11. Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney Jr J, Silverberg SJ, Bilezikian JP 2008 Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23:2018-2024
12. Raue F, Pichl J, Dorr HG, Schnabel D, Heidemann P, Hammersen G, Jaursch-Hancke C, Santen R, Schofl C, Wabitsch M, Haag C, Schulze E, Frank-Raue K 2011 Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia: a German survey. Clin Endocrinol (Oxf) 75:760-765
13. Goswami R, Sharma R, Sreenivas V, Gupta N, Ganapathy A, Das S 2012 Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 77:200-206
14. Nalichowski R, Keogh D, Chueh HC, Murphy SN 2006 Calculating the benefits of a Research Patient Data Repository. AMIA Annu Symp Proc 2006:1044
15. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH 2003 Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28:916-931 (Pubitemid 36936799)
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470 (Pubitemid 29135798)
17. Porter RH, Cox BG, Heaney D, Hostetter TH, Stinebaugh BJ, Suki WN 1978 Treatment of hypoparathyroid patients with chlorthalidone. N Engl J Med 298:577-581 (Pubitemid 8291638)
18. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J 2009 A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604-612
19. Clarke B, Leibson C, Emerson J, Ransom J, Lagast H, Co-morbid medical conditions associated with prevalent hypoparathyroidism: a population-based study. American Society of Bone and Mineral Research Annual Meeting, San Diego, CA, 2011, p S182 (Abstract SA0170)
20. Winer KK, Yanovski JA, Cutler Jr GB 1996 Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 276:631-636 (Pubitemid 26278069)
21. Winer KK, Yanovski JA, Sarani B, Cutler Jr GB 1998 A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83:3480-3486 (Pubitemid 28500875)
22. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler Jr GB 2003 Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214-4220 (Pubitemid 37153722)
23. Eaton LM, Camp JD, Love JG 1939 Symmetric cerebral calcification, particularly of the basal ganglia, demonstrable roentgenographically. Arch Neurol Psychiatry 41:921-942
24. Fénelon G, Gray F, Paillard F, Thibierge M, Mahieux F, Guillani A 1993 A prospective study of patients with CT detected pallidal calcifications. J Neurol Neurosurg Psychiatry 56:622-625 (Pubitemid 23203759)
25. Gomille T, Meyer RA, Falkai P, Gaebel W, Königshausen T, Christ F 2001 [Prevalence and clinical significance of computerized tomography verified idiopathic calcinosis of the basal ganglia]. Radiologe 41:205-210 (German)
26. Wang C, Li Y, Shi L, Ren J, Patti M, Wang T, de Oliveira JR, Sobrido MJ, Quintáns B, Baquero M, Cui X, Zhang XY, Wang L, Xu H, Wang J, Yao J, Dai X, Liu J, Zhang L, Ma H, Gao Y, Ma X, Feng S, Liu M, Wang QK, Forster IC, Zhang X, Liu JY 2012 Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 44:254-256
27. Winer KK, Sinaii N, Peterson D, Sainz Jr B, Cutler Jr GB 2008 Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab 93:3389-3395
28. Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler Jr GB 2010 Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab 95:2680-2688
29. Rubin MR, Sliney Jr J, McMahon DJ, Silverberg SJ, Bilezikian JP 2010 Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int 21:1927-1934
30. Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L 2011 The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res 26:2358-2370
31. Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS, Cutler Jr GB 2012 Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 97:391-399
32. Curhan GC, Willett WC, Speizer FE, Stampfer MJ 2001 Twenty-four-h urine chemistries and the risk of kidney stones among women and men. Kidney Int 59:2290-2298 (Pubitemid 32467623)